Physitrack: Preview Q2’23 - Redeye

Redeye provides an update on Physitrack ahead of its Q2’23-results (scheduled for 18 August), anticipating a steady quarter marked by favourable margin improvements. We have slightly adjusted our estimates, considering the emphasis on attracting higher-margin customers indicating less intense topline figures but enhancing operational efficiency.

Länk till analysen i sin helhet: https://www.redeye.se/research/927192/physitrack-preview-q223?utm_source=finwire&utm_medium=RSS